5Rickles FR,Edwards RL.Activation of blood coagulation in cancer:Trousseau's syndrome revisited.Blood,1983,62:14-31.
6WiegandUK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implamahle cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy [J]. Chest,2004,126(4):1177-1186.
7Gwozdziewiez M, Olsak P, Lonsky V. Re-operations for bleeding in cardiac surgery: Treatment strategy[J]. Biomed Pap Med Fac Univ Palacky Olomoue Czech Repub, 2008, 152( 1 ): 159-162.
8Pleym H,Wahba A, Videm V. et al. Increased Fibrinolysis and Platelet Activation in Elderly Patients Undergoing Coronary Bypass Surgery[J]. Anesth Analg,2006,102(3) :660 -667.
9Tsihlias J, Grossman HB. The utility of fibrin/fibrinogen degradation products in superficial bladder cancer. Urol Clin North Am, 2000, 27: 39-46.
10Shakur H, Elbourne D, Gulmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial ) : tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled triM. Trials, 2010, 16: 40.
